![](/img/cover-not-exists.png)
Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies
Hong, D. S., Sebti, S. M., Newman, R. A., Blaskovich, M. A., Ye, L., Gagel, R. F., Moulder, S., Wheler, J. J., Naing, A., Tannir, N. M., Ng, C. S., Sherman, S. I., El Naggar, A. K., Khan, R., Trent, JVolume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-09-1241
Date:
November, 2009
File:
PDF, 312 KB
english, 2009